Non-obstructive hypertrophic cardiomyopathy, or NHCM, is a rare heart condition that affects about 1 in 500 people. It's characterized by enlarged heart muscles, which can cause shortness of breath and chest pain.
- It's important to note that NHCM is not the same as hypertrophic cardiomyopathy (HCM). HCM is a more common, inherited condition that causes thickening of the muscle wall and may also lead to arrhythmias or heart failure.
- Hypertrophic cardiomyopathy is a disease that affects the heart muscle. It can lead to symptoms like shortness of breath, chest pain, and heart failure.
- Family history of this disease (particularly if there is more than one family member with it)
- Genetic mutation in the genes that control heart function (such as MYH7)
- Congenital defects in the heart that affect its structure or function
- Diabetes mellitus
- Coronary artery disease (CAD)
- Myocardial infarction (MI)
Chest pain,Palpitations,Dizziness and fainting,Shortness of breath when exercising or at rest,Fatigue, weakness, and tiredness
Beta blockers such as metoprolol (Lopressor, Toprol-XL), propranolol (Inderal, Innopran XL) or atenolol (Tenormin)
Calcium channel blockers such as verapamil (Verelan, Calan SR,) or diltiazem (Cardizem, Tiazac)